摘要
目的:探讨阿奇霉素与红霉素治疗小儿肺炎支原体肺炎的临床疗效。方法:将124例小儿肺炎支原体肺炎患儿随机分为两组,观察组68,对照组56例,观察组采用阿奇霉素序贯治疗,对照组采用红霉素连续静脉滴注,疗程均为2~3周。对两种治疗方案的临床疗效以及不良反应、住院时间、住院费用进行对比分析。结果:观察组痊愈42例,好转26例,总有效率100%,对照组,痊愈38例,好转18例,总有效率为100%,两组比较差异无显著性(P>0.05),但观察组的不良反应、住院时间、住院费用均明显低于对照组。结论:阿奇霉素序贯治疗小儿肺炎支原体肺炎有效、安全、经济。
Objective :To evaluate the cost-effectiveness of azithromycin and erythromyein in the treatment of myeoplasmal pneumonia in children.Methods: 124 mycoplasmal pneumonia patients were divided into two groups;the observation group(68 eases) and control group (56 eases).The observation group received azithromyein by sequential therapy.The control group received erythromyein by intravenous administration.AU the patients were treated for 2 or 3 week.A comparison was made between two groups in the way of pharmaeoeeonomies cost-effectiveness analysis. Results:The reeovery rates of two groups were all 100%. But the side effects, hospitalizing days and the average eost of the sequential therapy group were less than those of the group of erythromyein intravenous administration.Conclusion :Azithromycin sequential therapy in the treatment of mycoplasmal pneumonia can ensure curative effect,safety and economy.
出处
《现代医药卫生》
2009年第2期193-194,共2页
Journal of Modern Medicine & Health